Rapid nanopore sequencing and predictive susceptibility testing of positive blood cultures from intensive care patients with sepsis
Open Access
- 6 February 2024
- journal article
- research article
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 12 (2) , e0306523
Abstract
We aimed to evaluate the performance of Oxford Nanopore Technologies (ONT) sequencing from positive blood culture (BC) broths for bacterial identification and antimicrobial susceptibility prediction. Patients with suspected sepsis in four intensive care units were prospectively enrolled. Human-depleted DNA was extracted from positive BC broths and sequenced using ONT (MinION). Species abundance was estimated using Kraken2, and a cloud-based system (AREScloud) provided in silico predictive antimicrobial susceptibility testing (AST) from assembled contigs. Results were compared to conventional identification and phenotypic AST. Species-level agreement between conventional methods and AST predicted from sequencing was 94.2% (49/52), increasing to 100% in monomicrobial infections. In 262 high-quality AREScloud AST predictions across 24 samples, categorical agreement (CA) was 89.3%, with major error (ME) and very major error (VME) rates of 10.5% and 12.1%, respectively. Over 90% CA was achieved for some taxa (e.g., Staphylococcus aureus ) but was suboptimal for Pseudomonas aeruginosa . In 470 AST predictions across 42 samples, with both high quality and exploratory-only predictions, overall CA, ME, and VME rates were 87.7%, 8.3%, and 28.4%. VME rates were inflated by false susceptibility calls in a small number of species/antibiotic combinations with few representative resistant isolates. Time to reporting from sequencing could be achieved within 8–16 h from BC positivity. Direct sequencing from positive BC broths is feasible and can provide accurate predictive AST for some species. ONT-based approaches may be faster but significant improvements in accuracy are required before it can be considered for clinical use. IMPORTANCE: Sepsis and bloodstream infections carry a high risk of morbidity and mortality. Rapid identification and susceptibility prediction of causative pathogens, using Nanopore sequencing direct from blood cultures, may offer clinical benefit. We assessed this approach in comparison to conventional phenotypic methods and determined the accuracy of species identification and susceptibility prediction from genomic data. While this workflow holds promise, and performed well for some common bacterial species, improvements in sequencing accuracy and more robust predictive algorithms across a diverse range of organisms are required before this can be considered for clinical use. However, results could be achieved in timeframes that are faster than conventional phenotypic methods.Keywords
All Related Versions
Funding Information
- Queensland Government (Queensland Genomics)
- Brisbane Diamantina Health Partners (Health System Improvement Ideas Grant)
- DHAC | National Health and Medical Research Council (Early Career Research Fellowship (GNT1157530))
- DHAC | National Health and Medical Research Council (Centre of Research Excellence (APP2007007))
- DHAC | National Health and Medical Research Council (Investigator Grant (GNT1197743))
This publication has 30 references indexed in Scilit:
- CheckM2: a rapid, scalable and accurate tool for assessing microbial genome quality using machine learningNature Methods, 2023
- Oxford Nanopore R10.4 long-read sequencing enables the generation of near-finished bacterial genomes from pure cultures and metagenomes without short-read or reference polishingNature Methods, 2022
- BUSCO: Assessing Genomic Data Quality and BeyondCurrent Protocols, 2021
- Strengths and caveats of identifying resistance genes from whole genome sequencing dataExpert Review of Anti-infective Therapy, 2021
- AMRFinderPlus and the Reference Gene Catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulenceScientific Reports, 2021
- Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluidsNature Medicine, 2020
- Rapid identification of pathogens, antibiotic resistance genes and plasmids in blood cultures by nanopore sequencingScientific Reports, 2020
- Assembly of long, error-prone reads using repeat graphsNature Biotechnology, 2019
- Recovery of genomes from metagenomes via a dereplication, aggregation and scoring strategyNature Microbiology, 2018
- MEGAHIT v1.0: A fast and scalable metagenome assembler driven by advanced methodologies and community practicesMethods, 2016